Decoding immune-related gene-signatures in colorectal neoplasia

Area of Science:

• Immunology
• Oncology
• Genetics

Background:

• Colorectal cancer (CRC) presents a significant health challenge, particularly in Norway.
• The immune system's role in CRC is complex, influencing both protection and tumor progression.
• Understanding immune gene expression is crucial for identifying novel biomarkers.

Purpose of the Study:

• To screen immune-related genes in the Norwegian population.
• To identify specific genes associated with colorectal cancer and adenomatous polyps.
• To explore potential immune gene biomarkers for early detection of colorectal neoplasia.

Main Methods:

• Analysis of 579 immune genes using nCounter technology.
• Comparison of gene expression in tumor versus adjacent non-tumorous tissues.
• Quantitative reverse transcription polymerase chain reaction (RT-qPCR) validation across patient groups.

Main Results:

• Elevated expression of CXCL1, CXCL2, IL1B, IL6, CXCL8, PTGS2, and SPP1 was observed in CRC tissues.
• Significant expression changes in CXCL1, CXCL2, IL6, CXCL8, and PTGS2 were noted in adenomatous polyps.
• These genes indicate early involvement in colorectal carcinogenesis.

Conclusions:

• A unique immunological signature was identified in Norwegian colorectal neoplasia.
• CXCL1, CXCL2, IL1B, IL6, CXCL8, PTGS2, and SPP1 are highlighted as potential CRC biomarkers.
• Further research is needed to validate these biomarkers for non-invasive screening strategies.